NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

核醫學的全球市場:市場佔有率、規模、趨勢,產業分析 (各類型、各種模式、各用途、各最終用途、各地區),各部門預測 (2021年∼2028年)

Nuclear Medicine Market Share, Size, Trends, Industry Analysis Report, By Type ; By Modality ; By Application; By End-Use; By Regions; Segment Forecast, 2021 - 2028

出版商 Polaris Market Research 商品編碼 1004382
出版日期 內容資訊 英文 103 Pages
商品交期: 最快1-2個工作天內
價格
核醫學的全球市場:市場佔有率、規模、趨勢,產業分析 (各類型、各種模式、各用途、各最終用途、各地區),各部門預測 (2021年∼2028年) Nuclear Medicine Market Share, Size, Trends, Industry Analysis Report, By Type ; By Modality ; By Application; By End-Use; By Regions; Segment Forecast, 2021 - 2028
出版日期: 2021年04月01日內容資訊: 英文 103 Pages
簡介

全球核醫學的市場規模,至2028年達到121億7000萬美元。檢測準確度高和速度快速,患者體驗的改善等核醫學的各種優點,成為市場的大促進材料。各類型中診斷利用佔大半,不過,治療用途也逐漸擴大 (癌症、甲狀腺治療等)。各種模式中SPECT掃描主導目前的市場。在各地區中,北美各國為最大市場。

本報告提供全球核醫學的市場相關分析,技術概要和市場基本結構,主要的推動及阻礙市場要素,產業的向心力,整體市場規模趨勢預測,各類型、各種模式、各用途、各終端用戶、各地區的詳細趨勢,主要企業的簡介等資訊,為您概述為以下內容。

目錄

第1章 簡介

第2章 摘要整理

第3章 分析方法

第4章 核醫學市場洞察

  • 核醫學:產業概要
  • 核醫學的市場動態
    • 促進因素和機會
    • 阻礙因素與課題
  • 波特的五力分析
  • 核醫學市場:大環境分析
  • 價值鏈分析
  • 企業排行榜分析 (2020年)

第5章 核醫學市場:各種類的分析

  • 簡介
    • 市場佔有率:各類型 (2020年/2028年)
  • 診斷
    • 市場規模 (以金額為準,2016年∼2028年)
    • 市場規模:各地區 (以金額為準,2016年∼2028年)
  • 治療
  • 其他

第6章 核醫學市場:各種模式分析

  • 簡介
    • 市場佔有率:各種模式 (2020年/2028年)
  • β輻射體
  • PET (正子發射斷層掃描)
  • SPECT (單光子放射電腦斷層攝影)
  • α發射體
  • 近距離放射治療
  • 其他

第7章 核醫學市場:各用途分析

  • 簡介
    • 市場佔有率:各用途 (2020年/2028年)
  • 甲狀腺
  • 心臟疾病
  • 骨轉移
  • 腫瘤
  • 神經內科
  • 消化器官內科
  • 免疫疾病
  • 其他

第8章 核醫學市場:各終端用戶分析

  • 簡介
    • 市場佔有率:各終端用戶 (2020年/2028年)
  • 醫院
  • 診所、診斷中心
  • 研究機關
  • 其他

第9章 核醫學市場:各地區的分析

  • 簡介
    • 市場佔有率:各地區 (2020年/2028年)
  • 北美的核醫學市場
    • 市場規模:各國 (以金額為準,2016年∼2028年)
    • 市場規模:各類型 (以金額為準,2016年∼2028年)
    • 市場規模:各種模式 (以金額為準,2016年∼2028年)
    • 市場規模:各用途 (以金額為準,2016年∼2028年)
    • 市場規模:各終端用戶 (以金額為準,2016年∼2028年)
    • 美國
    • 加拿大
  • 歐洲的核醫學市場
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他的歐洲各國
  • 亞太地區的核醫學市場
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他的亞太地區各國
  • 南美的核醫學市場
    • 巴西
    • 墨西哥
    • 哥倫比亞
    • 其他的南美各國
  • 中東、非洲的核醫學市場
    • 沙烏地阿拉伯
    • 南非
    • 以色列
    • 阿拉伯聯合大公國 (UAE)
    • 其他的中東、非洲各國

第10章 競爭情形

  • 事業擴張、企業收購分析
  • 事業聯盟、合作,契約,展示會

第11章 企業簡介

  • Bracco Imaging S.P.A.
  • Lantheus Medical Imaging, Inc.
  • NTP Radioisotopes Soc, LTD
  • Eckert & Ziegler Group
  • Jubilant Pharma LLC
  • Australian Nuclear Science & Technology Organization
  • Cardinal Health
  • Isotopia Molecular Imaging Limited
  • Bayer AG
  • The Institute for Radioelements
  • Curium SAS
  • Advanced Accelerator Applications
  • Nordion, Inc.
  • Mallinckrodt
  • GE Healthcare
目錄
Product Code: PM1848

The global nuclear medicine market size is expected to reach USD 12.17 billion by 2028 according to a new study by Polaris Market Research. The report "Nuclear Medicine Market Share, Size, Trends, Industry Analysis Report, By Type (Diagnostic, Therapeutic, Others); By Modality (Beta-emitters, PET, SPECT, Alpha-emitters, Brachytherapy, Others); By Application; By End-Use; By Regions; Segment Forecast, 2021 - 2028" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The different types of nuclear medicine include diagnostic, therapeutic, and others. The diagnostic segment dominated the global radiopharmaceuticals market in 2020. However, nuclear medicine is increasingly being used in therapeutic procedures for the treatment of cancer and thyroid-related conditions. Radioimmunotherapy uses radiation therapy, immunotherapy, and radiotracers for the treatment of certain types of cancer. Brachytherapy uses iridium-192, which is introduced in the body for the destruction of cancer cells.

The market is segmented into Beta-emitters, PET, SPECT, Alpha-emitters, brachytherapy, and others, based on modality. The SPECT (Single-photon emission computed tomography) segment dominated the global Radiopharmaceuticals market in 2020. SPECT scan is a nuclear imaging test that creates 3-D images using a radioactive substance and a special camera.

Some radioisotopes used for SPECT scans include fluorine-18, xenon-133, iodine-123, and thallium-201 among others. SPECT scan examines blood flow to organs and the functioning of internal organs. SPECT scans are mostly used for the diagnosis of heart diseases, brain abnormalities, and bone disorders in the market.

The different applications of nuclear medicine in the market include thyroid, cardiology, bone metastasis, oncology, neurology, gastroenterology, immunology, and others. Nuclear medicine is used in neurology to accurately detect Alzheimer's diseases, reveal brain abnormalities, and support surgical planning.

The need for high detection accuracy, improved detection speed, and enhanced patient experience has increased the adoption of nuclear medicine. Nuclear medicine enables doctors to diagnose diseases and tumors or recurrence, radiation planning, localization, and track treatment progress.

The hospital segment dominated the global radiopharmaceuticals market in 2020. The growing need for early detection of severe ailments, growing geriatric population, and rising healthcare expenditure in developing countries, such as India, China, and Japan, boost the adoption of nuclear medicine in hospitals.

North America dominated the global radiopharmaceuticals market in 2020 and is expected to maintain its dominance over the forecast period. Rising occurrence of chronic diseases, advanced treatment options, early detection of severe medical conditions, and technological advancements are some factors boosting the adoption of nuclear medicine in the region.

Increasing applications in cancer detection and the presence of well-established healthcare infrastructure further increases the demand for Nuclear Medicine in North America. Asia-Pacific is expected to experience significant growth during the forecast period owing to the increasing geriatric population, rising spending on healthcare, and significant government investments aimed at providing improved healthcare services.

Some of the major market participants include Bracco Imaging S.P.A., Lantheus Medical Imaging, Inc., NTP Radioisotopes Soc, LTD, Eckert & Ziegler Group, Jubilant Pharma LLC, Australian Nuclear Science & Technology Organization, Cardinal Health, Isotopia Molecular Imaging Limited, Bayer AG, The Institute for Radioelements, Curium SAS, Advanced Accelerator Applications, Nordion, Inc., Mallinckrodt, and GE Healthcare.

Polaris Market Research has segmented the nuclear medicine market report on the basis of type, modality, application, end-use, and region:

Nuclear Medicine Type Outlook (Revenue, USD Million, 2016 - 2028)

Diagnostic

Therapeutic

Others

Nuclear Medicine Modality Outlook (Revenue, USD Million, 2016 - 2028)

Beta-emitters

PET

SPECT

Alpha-emitters

Brachytherapy

Others

Nuclear Medicine Application Outlook (Revenue, USD Million, 2016 - 2028)

Thyroid

Cardiology

Bone Metastasis

Oncology

Neurology

Gastroenterology

Immunology

Others

Nuclear Medicine End-User Outlook (Revenue, USD Million, 2016 - 2028)

Hospitals

Clinics and Diagnostic Centers

Research Institutes

Others

Nuclear Medicine Regional Outlook (Revenue, USD Million, 2016 - 2028)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

RoE

Asia Pacific

China

India

Japan

South Korea

RoAPAC

Latin America

Brazil

Mexico

Colombia

RoLATAM

Middle East & Africa

Saudi Arabia

South Africa

Israel

UAE

RoMEA

Table of Contents

1. Chapter 1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Chapter 2. Executive Summary

  • 2.1. Market Highlights

3. Chapter 3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Chapter 4. Nuclear Medicine Market Insights

  • 4.1. Nuclear Medicine - Industry snapshot
  • 4.2. Nuclear Medicine Market Dynamics
    • 4.2.1. Drivers and Opportunities
    • 4.2.2. Restraints and Challenges
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Threats of New Entrants
    • 4.3.3. Bargaining Power of Buyers
    • 4.3.4. Threats of Substitute
    • 4.3.5. Rivalry among existing firms
  • 4.4. Nuclear Medicine Market PESTLE Analysis
  • 4.5. Value Chain Analysis
  • 4.6. Competitive Ranking Analysis, 2020

5. Chapter 5. Nuclear Medicine Market Assessment by Type

  • 5.1. Introduction
    • 5.1.1. Global Nuclear Medicine Market Share, By Type, 2020 & 2028
  • 5.2. Diagnostic
    • 5.2.1. Global Nuclear Medicine Market, by Diagnostic, 2016-2028 (USD Million)
    • 5.2.2. Global Nuclear Medicine Market, by Diagnostic, by Region, 2016-2028 (USD Million)
  • 5.3. Therapeutic
    • 5.3.1. Global Nuclear Medicine Market, by Therapeutic, 2016-2028 (USD Million)
    • 5.3.2. Global Nuclear Medicine Market, by Therapeutic, by Region, 2016-2028 (USD Million)
  • 5.4. Others
    • 5.4.1. Global Nuclear Medicine Market, by Others, 2016-2028 (USD Million)
    • 5.4.2. Global Nuclear Medicine Market, by Others, by Region, 2016-2028 (USD Million)

6. Chapter 6. Nuclear Medicine Market Assessment by Modality

  • 6.1. Introduction
    • 6.1.1. Global Nuclear Medicine Market Share, By Modality, 2020 & 2028
  • 6.2. Beta-emitters
    • 6.2.1. Global Nuclear Medicine Market, by Beta-emitters, 2016-2028 (USD Million)
    • 6.2.2. Global Nuclear Medicine Market, by Beta-emitters, by Region, 2016-2028 (USD Million)
  • 6.3. PET
    • 6.3.1. Global Nuclear Medicine Market, by PET, 2016-2028 (USD Million)
    • 6.3.2. Global Nuclear Medicine Market, by PET, by Region, 2016-2028 (USD Million)
  • 6.4. SPECT
    • 6.4.1. Global Nuclear Medicine Market, by SPECT, 2016-2028 (USD Million)
    • 6.4.2. Global Nuclear Medicine Market, by SPECT, by Region, 2016-2028 (USD Million)
  • 6.5. Alpha-emitters
    • 6.5.1. Global Nuclear Medicine Market, by Alpha-emitters, 2016-2028 (USD Million)
    • 6.5.2. Global Nuclear Medicine Market, by Alpha-emitters, by Region, 2016-2028 (USD Million)
  • 6.6. Brachytherapy
    • 6.6.1. Global Nuclear Medicine Market, by Brachytherapy, 2016-2028 (USD Million)
    • 6.6.2. Global Nuclear Medicine Market, by Brachytherapy, by Region, 2016-2028 (USD Million)
  • 6.7. Others
    • 6.7.1. Global Nuclear Medicine Market, by Others, 2016-2028 (USD Million)
    • 6.7.2. Global Nuclear Medicine Market, by Others, by Region, 2016-2028 (USD Million)

7. Chapter 7. Nuclear Medicine Market Assessment by Application

  • 7.1. Introduction
    • 7.1.1. Global Nuclear Medicine Market Share, By Application, 2020 & 2028
  • 7.2. Thyroid
    • 7.2.1. Global Nuclear Medicine Market, by Thyroid, 2016-2028 (USD Million)
    • 7.2.2. Global Nuclear Medicine Market, by Thyroid, by Region, 2016-2028 (USD Million)
  • 7.3. Cardiology
    • 7.3.1. Global Nuclear Medicine Market, by Cardiology, 2016-2028 (USD Million)
    • 7.3.2. Global Nuclear Medicine Market, by Cardiology, by Region, 2016-2028 (USD Million)
  • 7.4. Bone Metastasis
    • 7.4.1. Global Nuclear Medicine Market, by Bone Metastasis, 2016-2028 (USD Million)
    • 7.4.2. Global Nuclear Medicine Market, by Bone Metastasis, by Region, 2016-2028 (USD Million)
  • 7.5. Oncology
    • 7.5.1. Global Nuclear Medicine Market, by Oncology, 2016-2028 (USD Million)
    • 7.5.2. Global Nuclear Medicine Market, by Oncology, by Region, 2016-2028 (USD Million)
  • 7.6. Neurology
    • 7.6.1. Global Nuclear Medicine Market, by Neurology, 2016-2028 (USD Million)
    • 7.6.2. Global Nuclear Medicine Market, by Neurology, by Region, 2016-2028 (USD Million)
  • 7.7. Gastroenterology
    • 7.7.1. Global Nuclear Medicine Market, by Gastroenterology, 2016-2028 (USD Million)
    • 7.7.2. Global Nuclear Medicine Market, by Gastroenterology, by Region, 2016-2028 (USD Million)
  • 7.8. Immunology
    • 7.8.1. Global Nuclear Medicine Market, by Immunology, 2016-2028 (USD Million)
    • 7.8.2. Global Nuclear Medicine Market, by Immunology, by Region, 2016-2028 (USD Million)
  • 7.9. Others
    • 7.9.1. Global Nuclear Medicine Market, by Others, 2016-2028 (USD Million)
    • 7.9.2. Global Nuclear Medicine Market, by Others, by Region, 2016-2028 (USD Million)

8. Chapter 8. Nuclear Medicine Market Assessment by End-User

  • 8.1. Introduction
    • 8.1.1. Global Nuclear Medicine Market Share, By End-User, 2020 & 2028
  • 8.2. Hospitals
    • 8.2.1. Global Nuclear Medicine Market, by Hospitals, 2016-2028 (USD Million)
    • 8.2.2. Global Nuclear Medicine Market, by Hospitals, by Region, 2016-2028 (USD Million)
  • 8.3. Clinics and Diagnostic Centers
    • 8.3.1. Global Nuclear Medicine Market, by Clinics and Diagnostic Centers, 2016-2028 (USD Million)
    • 8.3.2. Global Nuclear Medicine Market, by Clinics and Diagnostic Centers, by Region, 2016-2028 (USD Million)
  • 8.4. Research Institutes
    • 8.4.1. Global Nuclear Medicine Market, by Research Institutes, 2016-2028 (USD Million)
    • 8.4.2. Global Nuclear Medicine Market, by Research Institutes, by Region, 2016-2028 (USD Million)
  • 8.5. Others
    • 8.5.1. Global Nuclear Medicine Market, by Others, 2016-2028 (USD Million)
    • 8.5.2. Global Nuclear Medicine Market, by Others, by Region, 2016-2028 (USD Million)

9. Chapter 9. Nuclear Medicine Market Assessment by Geography

  • 9.1. Introduction
    • 9.1.1. Global Nuclear Medicine Market Share, By Geography, 2020 & 2028
  • 9.2. Nuclear Medicine Market - North America
    • 9.2.1. North America: Nuclear Medicine Market, by Country, 2016-2028 (USD Million)
    • 9.2.2. North America: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
    • 9.2.3. North America: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
    • 9.2.4. North America: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
    • 9.2.5. North America: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
    • 9.2.6. Nuclear Medicine Market - U.S.
      • 9.2.6.1. U.S.: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
      • 9.2.6.2. U.S.: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
      • 9.2.6.3. U.S.: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
      • 9.2.6.4. U.S.: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
    • 9.2.7. Nuclear Medicine Market - Canada
      • 9.2.7.1. Canada: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
      • 9.2.7.2. Canada: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
      • 9.2.7.3. Canada: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
      • 9.2.7.4. Canada: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • 9.3. Nuclear Medicine Market - Europe
    • 9.3.1. Europe: Nuclear Medicine Market, by Country, 2016-2028 (USD Million)
    • 9.3.2. Europe: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
    • 9.3.3. Europe: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
    • 9.3.4. Europe: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
    • 9.3.5. Europe: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
    • 9.3.6. Nuclear Medicine Market - Germany
      • 9.3.6.1. Germany: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
      • 9.3.6.2. Germany: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
      • 9.3.6.3. Germany: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
      • 9.3.6.4. Germany: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
    • 9.3.7. Nuclear Medicine Market - UK
      • 9.3.7.1. UK: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
      • 9.3.7.2. UK: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
      • 9.3.7.3. UK: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
      • 9.3.7.4. UK: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
    • 9.3.8. Nuclear Medicine Market - France
      • 9.3.8.1. France: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
      • 9.3.8.2. France: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
      • 9.3.8.3. France: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
      • 9.3.8.4. France: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
    • 9.3.9. Nuclear Medicine Market - Italy
      • 9.3.9.1. Italy: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
      • 9.3.9.2. Italy: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
      • 9.3.9.3. Italy: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
      • 9.3.9.4. Italy: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
    • 9.3.10. Nuclear Medicine Market - Spain
      • 9.3.10.1. Spain: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
      • 9.3.10.2. Spain: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
      • 9.3.10.3. Spain: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
      • 9.3.10.4. Spain: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
    • 9.3.11. Nuclear Medicine Market - Rest of Europe
      • 9.3.11.1. Rest of Europe: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
      • 9.3.11.2. Rest of Europe: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
      • 9.3.11.3. Rest of Europe: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
      • 9.3.11.4. Rest of Europe: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • 9.4. Nuclear Medicine Market - Asia-Pacific
    • 9.4.1. Asia-Pacific: Nuclear Medicine Market, by Country, 2016-2028 (USD Million)
    • 9.4.2. Asia-Pacific: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
    • 9.4.3. Asia-Pacific: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
    • 9.4.4. Asia-Pacific: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
    • 9.4.5. Asia-Pacific: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
    • 9.4.6. Nuclear Medicine Market - China
      • 9.4.6.1. China: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
      • 9.4.6.2. China: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
      • 9.4.6.3. China: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
      • 9.4.6.4. China: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
    • 9.4.7. Nuclear Medicine Market - India
      • 9.4.7.1. India: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
      • 9.4.7.2. India: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
      • 9.4.7.3. India: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
      • 9.4.7.4. India: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
    • 9.4.8. Nuclear Medicine Market - Japan
      • 9.4.8.1. Japan: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
      • 9.4.8.2. Japan: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
      • 9.4.8.3. Japan: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
      • 9.4.8.4. Japan: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
    • 9.4.9. Nuclear Medicine Market - South Korea
      • 9.4.9.1. South Korea: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
      • 9.4.9.2. South Korea: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
      • 9.4.9.3. South Korea: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
      • 9.4.9.4. South Korea: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
    • 9.4.10. Nuclear Medicine Market - Rest of APAC
      • 9.4.10.1. Rest of APAC: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
      • 9.4.10.2. Rest of APAC: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
      • 9.4.10.3. Rest of APAC: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
      • 9.4.10.4. Rest of APAC: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • 9.5. Nuclear Medicine Market - Latin America
    • 9.5.1. Latin America: Nuclear Medicine Market, by Country, 2016-2028 (USD Million)
    • 9.5.2. Latin America: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
    • 9.5.3. Latin America: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
    • 9.5.4. Latin America: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
    • 9.5.5. Latin America: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
    • 9.5.6. Nuclear Medicine Market - Brazil
      • 9.5.6.1. Brazil: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
      • 9.5.6.2. Brazil: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
      • 9.5.6.3. Brazil: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
      • 9.5.6.4. Brazil: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
    • 9.5.7. Nuclear Medicine Market - Mexico
      • 9.5.7.1. Mexico: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
      • 9.5.7.2. Mexico: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
      • 9.5.7.3. Mexico: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
      • 9.5.7.4. Mexico: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
    • 9.5.8. Nuclear Medicine Market - Colombia
      • 9.5.8.1. Colombia: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
      • 9.5.8.2. Colombia: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
      • 9.5.8.3. Colombia: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
      • 9.5.8.4. Colombia: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
    • 9.5.9. Nuclear Medicine Market - Rest of Latin America
      • 9.5.9.1. Rest of Latin America: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
      • 9.5.9.2. Rest of Latin America: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
      • 9.5.9.3. Rest of Latin America: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
      • 9.5.9.4. Rest of Latin America: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • 9.6. Nuclear Medicine Market - Middle East and Africa
    • 9.6.1. Middle East & Africa: Nuclear Medicine Market, by Country, 2016-2028 (USD Million)
    • 9.6.2. Middle East & Africa: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
    • 9.6.3. Middle East & Africa: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
    • 9.6.4. Middle East & Africa: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
    • 9.6.5. Middle East & Africa: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
    • 9.6.6. Nuclear Medicine Market - Saudi Arabia
      • 9.6.6.1. Saudi Arabia: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
      • 9.6.6.2. Saudi Arabia: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
      • 9.6.6.3. Saudi Arabia: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
      • 9.6.6.4. Saudi Arabia: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
    • 9.6.7. Nuclear Medicine Market - South Africa
      • 9.6.7.1. South Africa: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
      • 9.6.7.2. South Africa: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
      • 9.6.7.3. South Africa: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
      • 9.6.7.4. South Africa: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
    • 9.6.8. Nuclear Medicine Market - Israel
      • 9.6.8.1. Israel: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
      • 9.6.8.2. Israel: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
      • 9.6.8.3. Israel: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
      • 9.6.8.4. Israel: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
    • 9.6.9. Nuclear Medicine Market - UAE
      • 9.6.9.1. UAE: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
      • 9.6.9.2. UAE: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
      • 9.6.9.3. UAE: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
      • 9.6.9.4. UAE: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
    • 9.6.10. Nuclear Medicine Market - Rest of MEA
      • 9.6.10.1. Rest of MEA: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
      • 9.6.10.2. Rest of MEA: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
      • 9.6.10.3. Rest of MEA: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
      • 9.6.10.4. Rest of MEA: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)

10. Chapter 10. Competitive Landscape

  • 10.1. Expansion and Product Launch Analysis
    • 10.1.1. Expansion
    • 10.1.2. Product Launch
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Chapter 11. Company Profiles

  • 11.1. Bracco Imaging S.P.A.
    • 11.1.1. Business Overview
    • 11.1.2. Financial Snapshot
    • 11.1.3. Products and Services Benchmarking
    • 11.1.4. Recent Developments
  • 11.2. Lantheus Medical Imaging, Inc.
    • 11.2.1. Business Overview
    • 11.2.2. Financial Snapshot
    • 11.2.3. Products and Services Benchmarking
    • 11.2.4. Recent Developments
  • 11.3. NTP Radioisotopes Soc, LTD
    • 11.3.1. Business Overview
    • 11.3.2. Financial Snapshot
    • 11.3.3. Products and Services Benchmarking
    • 11.3.4. Recent Developments
  • 11.4. Eckert & Ziegler Group
    • 11.4.1. Business Overview
    • 11.4.2. Financial Snapshot
    • 11.4.3. Products and Services Benchmarking
    • 11.4.4. Recent Developments
  • 11.5. Jubilant Pharma LLC
    • 11.5.1. Business Overview
    • 11.5.2. Financial Snapshot
    • 11.5.3. Products and Services Benchmarking
    • 11.5.4. Recent Developments
  • 11.6. Australian Nuclear Science & Technology Organization
    • 11.6.1. Business Overview
    • 11.6.2. Financial Snapshot
    • 11.6.3. Products and Services Benchmarking
    • 11.6.4. Recent Developments
  • 11.7. Cardinal Health
    • 11.7.1. Business Overview
    • 11.7.2. Financial Snapshot
    • 11.7.3. Products and Services Benchmarking
    • 11.7.4. Recent Developments
  • 11.8. Isotopia Molecular Imaging Limited
    • 11.8.1. Business Overview
    • 11.8.2. Financial Snapshot
    • 11.8.3. Products and Services Benchmarking
    • 11.8.4. Recent Developments
  • 11.9. Bayer AG
    • 11.9.1. Business Overview
    • 11.9.2. Financial Snapshot
    • 11.9.3. Products and Services Benchmarking
    • 11.9.4. Recent Developments
  • 11.10. The Institute for Radioelements
    • 11.10.1. Business Overview
    • 11.10.2. Financial Snapshot
    • 11.10.3. Products and Services Benchmarking
    • 11.10.4. Recent Developments
  • 11.11. Curium SAS
    • 11.11.1. Business Overview
    • 11.11.2. Financial Snapshot
    • 11.11.3. Products and Services Benchmarking
    • 11.11.4. Recent Developments
  • 11.12. Advanced Accelerator Applications
    • 11.12.1. Business Overview
    • 11.12.2. Financial Snapshot
    • 11.12.3. Products and Services Benchmarking
    • 11.12.4. Recent Developments
  • 11.13. Nordion, Inc.
    • 11.13.1. Business Overview
    • 11.13.2. Financial Snapshot
    • 11.13.3. Products and Services Benchmarking
    • 11.13.4. Recent Developments
  • 11.14. Mallinckrodt
    • 11.14.1. Business Overview
    • 11.14.2. Financial Snapshot
    • 11.14.3. Products and Services Benchmarking
    • 11.14.4. Recent Developments
  • 11.15. GE Healthcare
    • 11.15.1. Business Overview
    • 11.15.2. Financial Snapshot
    • 11.15.3. Products and Services Benchmarking
    • 11.15.4. Recent Developments

List of Tables

  • Table 1 Drivers and Inhibitors for Global Market
  • Table 2 Restraints Global Market
  • Table 3 Global Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 4 Global Nuclear Medicine Market, by Diagnostic, by Region, 2016-2028 (USD Million)
  • Table 5 Global Nuclear Medicine Market, by Therapeutic, by Region, 2016-2028 (USD Million)
  • Table 6 Global Nuclear Medicine Market, by Others, by Region, 2016-2028 (USD Million)
  • Table 7 Global Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 8 Global Nuclear Medicine Market, by Beta-emitters, by Region, 2016-2028 (USD Million)
  • Table 9 Global Nuclear Medicine Market, by PET, by Region, 2016-2028 (USD Million)
  • Table 10 Global Nuclear Medicine Market, by SPECT, by Region, 2016-2028 (USD Million)
  • Table 11 Global Nuclear Medicine Market, by Alpha-emitters, by Region, 2016-2028 (USD Million)
  • Table 12 Global Nuclear Medicine Market, by Brachytherapy, by Region, 2016-2028 (USD Million)
  • Table 13 Global Nuclear Medicine Market, by Others, by Region, 2016-2028 (USD Million)
  • Table 14 Global Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 15 Global Nuclear Medicine Market, by Thyroid, by Region, 2016-2028 (USD Million)
  • Table 16 Global Nuclear Medicine Market, by Cardiology, by Region, 2016-2028 (USD Million)
  • Table 17 Global Nuclear Medicine Market, by Bone Metastasis, by Region, 2016-2028 (USD Million)
  • Table 18 Global Nuclear Medicine Market, by Oncology, by Region, 2016-2028 (USD Million)
  • Table 19 Global Nuclear Medicine Market, by Neurology, by Region, 2016-2028 (USD Million)
  • Table 20 Global Nuclear Medicine Market, by Gastroenterology, by Region, 2016-2028 (USD Million)
  • Table 21 Global Nuclear Medicine Market, by Immunology, by Region, 2016-2028 (USD Million)
  • Table 22 Global Nuclear Medicine Market, by Others, by Region, 2016-2028 (USD Million)
  • Table 23 Global Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 24 Global Nuclear Medicine Market, by Hospitals, by Region, 2016-2028 (USD Million)
  • Table 25 Global Nuclear Medicine Market, by Clinics and Diagnostic Centers, by Region, 2016-2028 (USD Million)
  • Table 26 Global Nuclear Medicine Market, by Research Institutes, by Region, 2016-2028 (USD Million)
  • Table 27 Global Nuclear Medicine Market, by Others, by Region, 2016-2028 (USD Million)
  • Table 28 Global Nuclear Medicine Market, By Geography, 2016 - 2028 (USD Million)
  • Table 29 North America: Nuclear Medicine Market, by Country, 2016-2028 (USD Million)
  • Table 30 North America: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 31 North America: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 32 North America: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 33 North America: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 34 U.S.: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 35 U.S.: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 36 U.S.: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 37 U.S.: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 38 Canada: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 39 Canada: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 40 Canada: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 41 Canada: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 42 Europe: Nuclear Medicine Market, by Country, 2016-2028 (USD Million)
  • Table 43 Europe: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 44 Europe: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 45 Europe: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 46 Europe: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 47 Germany: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 48 Germany: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 49 Germany: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 50 Germany: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 51 UK: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 52 UK: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 53 UK: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 54 UK: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 55 France: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 56 France: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 57 France: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 58 France: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 59 Italy: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 60 Italy: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 61 Italy: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 62 Italy: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 63 Spain: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 64 Spain: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 65 Spain: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 66 Spain: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 67 Rest of Europe: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 68 Rest of Europe: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 69 Rest of Europe: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 70 Rest of Europe: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 71 Asia-Pacific: Nuclear Medicine Market, by Country, 2016-2028 (USD Million)
  • Table 72 Asia-Pacific: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 73 Asia-Pacific: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 74 Asia-Pacific: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 75 Asia-Pacific: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 76 China: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 77 China: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 78 China: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 79 China: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 80 India: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 81 India: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 82 India: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 83 India: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 84 Japan: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 85 Japan: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 86 Japan: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 87 Japan: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 88 South Korea: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 89 South Korea: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 90 South Korea: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 91 South Korea: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 92 Rest of APAC: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 93 Rest of APAC: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 94 Rest of APAC: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 95 Rest of APAC: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 96 Latin America: Nuclear Medicine Market, by Country, 2016-2028 (USD Million)
  • Table 97 Latin America: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 98 Latin America: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 99 Latin America: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 100 Latin America: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 101 Brazil: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 102 Brazil: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 103 Brazil: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 104 Brazil: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 105 Mexico: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 106 Mexico: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 107 Mexico: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 108 Mexico: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 109 Colombia: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 110 Colombia: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 111 Colombia: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 112 Colombia: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 113 Rest of Latin America: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 114 Rest of Latin America: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 115 Rest of Latin America: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 116 Rest of Latin America: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 117 Middle East & Africa: Nuclear Medicine Market, by Country, 2016-2028 (USD Million)
  • Table 118 Middle East & Africa: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 119 Middle East & Africa: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 120 Middle East & Africa: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 121 Middle East & Africa: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 122 Saudi Arabia: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 123 Saudi Arabia: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 124 Saudi Arabia: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 125 Saudi Arabia: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 126 South Africa: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 127 South Africa: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 128 South Africa: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 129 South Africa: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 130 Israel: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 131 Israel: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 132 Israel: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 133 Israel: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 134 UAE: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 135 UAE: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 136 UAE: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 137 UAE: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)
  • Table 138 Rest of MEA: Nuclear Medicine Market, By Type, 2016 - 2028 (USD Million)
  • Table 139 Rest of MEA: Nuclear Medicine Market, By Modality, 2016 - 2028 (USD Million)
  • Table 140 Rest of MEA: Nuclear Medicine Market, By Application, 2016 - 2028 (USD Million)
  • Table 141 Rest of MEA: Nuclear Medicine Market, By End-User, 2016 - 2028 (USD Million)

List of Figures

FIG. 1 Market snapshot

FIG. 2 Market segmentation & scope

FIG. 3 Global Nuclear Medicine market size and growth prospects, 2016 - 2028

FIG. 4 Value chain analysis

FIG. 5 Nuclear Medicine market dynamics

FIG. 6 Key market opportunities - prioritized

FIG. 7 Industry analysis - Porter's

FIG. 8 PESTEL analysis

FIG. 9 Global Nuclear Medicine market share by Type, 2020 & 2028

FIG. 10 Global Nuclear Medicine market share by Modality, 2020 & 2028

FIG. 11 Global Nuclear Medicine market share by Application, 2020 & 2028

FIG. 12 Global Nuclear Medicine market share by End-User, 2020 & 2028

FIG. 13 Global Nuclear Medicine market share by Region, 2020 & 2028

FIG. 14 Competitive environment

FIG. 15 Strategy framework